50
PL03.10 Adjuvant Chemotherapy (CT) vs CT-immunotherapy for R0 Stage IB-IIIA NSCLC Patients (NADIM ADJUVANT): a Randomized, Phase 3 Trial
20
Life cycle assessment method applied to a carbon-negative energy process
20
Artificial intelligence for diabetes care: current and future prospects
20
Host cell protein detection via surfactant-assisted acid precipitation
20
Acute Respiratory Distress Syndrome
